Work

072 Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function

Year: 2022

Type: article

Source: European Journal of Obstetrics & Gynecology and Reproductive Biology

DOI: 10.1016/j.ejogrb.2022.02.101

Authors: A.L.L.F. van der Kooi, M. van Dijk, L. Broer, M. van den Berg, J. Laven, F. van Leeuwen, C. Ronckers, M. van der Heiden-van der Loo, M. Hudson, J. Byrne, S. Pluijm, C. Spix, P. Kaatsch, L. Kremer, Y. Yasui, J. Brooke, A. Uitterlinden, M. van den Heuvel-Eibrink, E. van Dulmen-den Broeder

Institutions: Erasmus MC, Amsterdam University Medical Centers, The Netherlands Cancer Institute, Princess Máxima Center, St. Jude Children's Research Hospital, Boyne Research Institute

Language: English

Topic: Reproductive Biology and Fertility

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3122938191

FWCI: 0.398

Cites:

Cited by: 2

Related to: 10